ARDELYX, INC. Effective Tax Rate
ARDELYX, INC. (ARDX) reported Effective Tax Rate of -1.70% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-02-19
- ARDELYX, INC. effective income tax rate reconciliation, percent for fiscal 2025 was -1.70%.
- ARDELYX, INC. effective income tax rate reconciliation, percent for fiscal 2024 was -0.60%.
- ARDELYX, INC. effective income tax rate reconciliation, percent for fiscal 2023 was -0.90%.
- ARDELYX, INC. effective income tax rate reconciliation, percent for fiscal 2022 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -1.70% 10-K · filed 2026-02-19 | |
| 2024-12-31 | -0.60% 10-K · filed 2026-02-19 | |
| 2023-12-31 | -0.90% 10-K · filed 2026-02-19 | -0.80% 10-K · filed 2024-02-22 |
| 2022-12-31 | 0.00% 10-K · filed 2025-02-20 | |
| 2021-12-31 | 0.00% 10-K · filed 2024-02-22 | |
| 2020-12-31 | 0.00% 10-K · filed 2023-03-02 | |
| 2019-12-31 | -0.30% 10-K · filed 2022-02-28 | |
| 2018-12-31 | 0.00% 10-K · filed 2020-03-06 | |
| 2017-12-31 | -1.90% 10-K · filed 2020-03-06 | |
| 2016-12-31 | 0.00% 10-K · filed 2018-03-14 | |
| 2015-12-31 | 0.10% 10-K · filed 2018-03-14 | |
| 2014-12-31 | -2.10% 10-K · filed 2017-02-17 | |
| 2013-12-31 | -2.20% 10-K · filed 2016-03-04 | |
| 2012-12-31 | 0.00% 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |